BOSTON, June 17, 2024 /PRNewswire/ -- T1D Exchange, a nonprofit organization that drives meaningful research and improvement in care and outcomes in type 1 and type 2 diabetes, today announced ...

Please provide your email address to receive an email when new articles are posted on . ORLANDO — In this video exclusive, Osagie Ebekozien, MD, MPH, CPHQ, chief medical officer at T1D Exchange ...

While insulin remains essential for treating T1D, new thinking is that weight loss with GLP-1 RAs would also enable insulin dose reduction and add cardiorenal benefit in those with overweight or ...

Take the type 1 diabetes (T1D) space, as one example. Today, new and exciting advancements are working to reduce barriers, increase access and expand optionality when it comes to early T1D ...

As a freelance writer, she focuses on diabetes content and has written for T1D Exchange and Beyond Type 1. When away from her desk, Kourtney enjoys reading, traveling, baking and trying new ...

Empagliflozin vs placebo was associated with greater reductions in risk for cardiovascular disease among patients with type 1 diabetes. Sodium–glucose cotransporter inhibitors (SGLTis) are ...

Visalia high school student Tylor Inglehart, 16, will be attending the Breakthrough T1D 2025 Children’s Congress in Washington, D.C. Inglehart will advocate for continued federal funding for ...